Most common muscle relaxers are not directly toxic to healthy kidneys, but several of them pose real risks if your kidney function is already reduced. The core issue is clearance: your kidneys are responsible for flushing these drugs and their byproducts out of your body. When kidney function declines, muscle relaxers can build up in your bloodstream, reaching levels that cause excessive sedation, dangerously low blood pressure, or in rare cases, further kidney damage.
The risk varies significantly depending on which muscle relaxer you’re taking and how well your kidneys are working. Some are officially contraindicated in severe kidney disease, while others simply need a dose adjustment. Here’s what you need to know about each one.
Baclofen: The Highest-Risk Option
Baclofen is the muscle relaxer most strongly linked to dangerous buildup in people with reduced kidney function. Clinical guidelines published in the American Journal of Kidney Diseases in 2025 flag baclofen for dose adjustment once your estimated kidney filtration rate (eGFR) drops below 60, which marks the beginning of moderate chronic kidney disease. When baclofen accumulates, it causes increasing drowsiness, lethargy, and heavy sedation that can progress to confusion or even coma.
Experts recommend reducing the dose for people with moderate kidney impairment (eGFR between 30 and 60) and avoiding baclofen entirely if kidney function is severely reduced (eGFR below 30) or if you’re on dialysis. If you’re taking baclofen and notice unusual drowsiness or mental fogginess, that could be a sign your kidneys aren’t clearing the drug fast enough.
Tizanidine: Slower Clearance, Lower Threshold
Tizanidine requires caution at a different kidney threshold. When kidney filtration drops below about 25 mL/min (roughly stage 4 kidney disease), the body’s ability to clear tizanidine falls by more than 50%. That means the drug lingers in your system at concentrations much higher than intended, increasing the risk of low blood pressure and excessive sedation.
The standard approach for people with impaired kidneys is to start at a lower dose and increase cautiously if needed, rather than taking it more frequently. If you have known kidney problems and your doctor prescribes tizanidine, the dose should reflect your current kidney function.
Metaxalone: Contraindicated in Severe Cases
Metaxalone (sold as Skelaxin) carries an FDA contraindication for anyone with severe kidney impairment. The drug label is explicit: do not use it if you have significantly reduced kidney function. For mild to moderate kidney disease, the FDA allows cautious use with closer monitoring, but it’s not considered a first-choice option when kidney health is a concern.
Methocarbamol: Watch the Formulation
Methocarbamol (Robaxin) is cleared primarily through the kidneys, with all major metabolites exiting via urine. The oral form can be used cautiously in mild to moderate kidney impairment, but the IV formulation is a different story entirely. IV methocarbamol contains an inactive ingredient called polyethylene glycol, which is independently linked to metabolic acidosis, kidney injury, and dangerous shifts in blood chemistry. The IV version is flatly contraindicated in kidney disease. If you’re taking oral methocarbamol and have any degree of kidney impairment, your prescriber should be monitoring you more closely than usual.
Cyclobenzaprine: Primarily a Liver Concern
Cyclobenzaprine (Flexeril) stands apart from the others because it’s processed almost entirely by the liver before being sent to the kidneys for excretion. It’s broken down by liver enzymes and leaves the body mainly as inactive byproducts. This makes it less of a direct kidney concern than baclofen or tizanidine, though the kidneys still handle the final elimination step. People with severe kidney disease should still use it cautiously, but it’s generally considered a lower-risk option from a kidney standpoint compared to other muscle relaxers.
How Muscle Relaxers Can Harm Kidneys Indirectly
Beyond the drug itself accumulating, muscle relaxers can cause kidney problems through a less obvious pathway: prolonged immobility. All centrally acting muscle relaxers cause some degree of sedation. In rare cases, particularly when combined with other sedating medications or alcohol, that sedation can become deep enough that a person remains in one position for an extended period. Prolonged immobility can lead to muscle tissue breakdown, a condition called rhabdomyolysis, where damaged muscle fibers release their contents into the bloodstream. Those proteins and electrolytes can overwhelm the kidneys and cause acute kidney injury.
This scenario is uncommon with normal use at prescribed doses, but it becomes more likely when muscle relaxers accumulate due to poor kidney clearance, creating a feedback loop: reduced kidney function leads to drug buildup, which leads to deeper sedation, which can lead to immobility, which can further damage the kidneys.
Safer Options for Muscle Pain With Kidney Disease
If you have chronic kidney disease and need relief from muscle spasms or pain, several alternatives carry less kidney risk. The National Kidney Foundation highlights topical pain relievers as a strong option. Products containing menthol, capsaicin, lidocaine, or camphor (brands like Icy Hot, Biofreeze, Bengay, and Salonpas) work locally on the skin and don’t enter the bloodstream in meaningful amounts. When used as directed, they have no expected kidney-related safety concerns.
Topical diclofenac gel (Voltaren), which is technically an anti-inflammatory rather than a muscle relaxer, can also be safer for people with kidney disease than oral anti-inflammatory drugs. Because it’s applied directly to the skin over the affected area, very little of the drug reaches the bloodstream, reducing the risk of kidney damage that oral NSAIDs carry.
Non-drug approaches also deserve serious consideration. Physical therapy, stretching, yoga, massage, acupuncture, and tai chi are all recognized by the National Kidney Foundation as effective components of pain management that carry zero kidney risk. For many people with chronic musculoskeletal pain, combining a topical product with one or more of these therapies provides meaningful relief without putting the kidneys at risk.
Acetaminophen (Tylenol) is generally safe for kidneys at recommended doses and can help with the pain component of muscle spasms, though it won’t address the spasm itself the way a true muscle relaxer does.
What Matters Most
If your kidneys are healthy, short-term use of most muscle relaxers at standard doses is unlikely to cause kidney damage. The real concern is for people who already have some degree of kidney impairment, even if they don’t know it. Kidney function naturally declines with age, and many people have mild to moderate chronic kidney disease without symptoms. A simple blood test measuring your eGFR can clarify where you stand and whether your muscle relaxer needs a dose adjustment or a switch to something safer.